Revolution Medicines, Inc. Warrant – NASDAQ:RVMDW

Revolution Medicines, Inc. Warrant stock price today

$0.21
-0.04
-16.73%
Financial Health
0
1
2
3
4
5
6
7
8
9

Revolution Medicines, Inc. Warrant stock price monthly change

+32.63%
month

Revolution Medicines, Inc. Warrant stock price quarterly change

+32.63%
quarter

Revolution Medicines, Inc. Warrant stock price yearly change

-23.64%
year

Revolution Medicines, Inc. Warrant key metrics

Market Cap
 28.49M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Revolution Medicines, Inc. Warrant stock price history

Revolution Medicines, Inc. Warrant stock forecast

Revolution Medicines, Inc. Warrant financial statements

Profit Margin

Revolution Medicines, Inc. Warrant (NASDAQ:RVMDW): Profit margin
2023 11.58M -436.36M -3768.28%
RVMDW income statement history

Debt to Assets

Revolution Medicines, Inc. Warrant (NASDAQ:RVMDW): Debt to assets
2017 15077000 10.54M 69.95%
2023 2061705000 235.51M 11.42%
RVMDW balance sheet history

Cash Flow

Revolution Medicines, Inc. Warrant (NASDAQ:RVMDW): Cash Flow
2017 -25.14M -1.57M 22.66M
2019 -49.61M -101.96M 98.65M
2022 -224.40M -24.11M 301.43M
2023 -350.57M -342.59M 1.22B
RVMDW cash flow history

Revolution Medicines, Inc. Warrant alternative data

Revolution Medicines, Inc. Warrant
Employees

Revolution Medicines, Inc. Warrant (NASDAQ:RVMDW): Employee count
Dec 2023 338
Jan 2024 338
Feb 2024 338
Mar 2024 378
Apr 2024 378
May 2024 378
Jun 2024 411
Jul 2024 411
Dec 2024 490

Revolution Medicines, Inc. Warrant other data

Frequently Asked Questions (FAQ)

  • What's the price of Revolution Medicines, Inc. Warrant stock today?

    One share of Revolution Medicines, Inc. Warrant stock can currently be purchased for approximately $0.21.

  • When is Revolution Medicines, Inc. Warrant's next earnings date?

    Unfortunately, Revolution Medicines, Inc. Warrant's (RVMDW) next earnings date is currently unknown.

  • Does Revolution Medicines, Inc. Warrant pay dividends?

    No, Revolution Medicines, Inc. Warrant does not pay dividends.

  • How much money does Revolution Medicines, Inc. Warrant make?

    Revolution Medicines, Inc. Warrant has a market capitalization of 28.49M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 73.06% to 11.58M US dollars.

  • What is Revolution Medicines, Inc. Warrant's stock symbol?

    Revolution Medicines, Inc. Warrant is traded on the NASDAQ under the ticker symbol "RVMDW".

  • What is Revolution Medicines, Inc. Warrant's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Revolution Medicines, Inc. Warrant?

    Shares of Revolution Medicines, Inc. Warrant can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Revolution Medicines, Inc. Warrant have?

    As Dec 2024, Revolution Medicines, Inc. Warrant employs 490 workers, which is 19% more then previous month and 30% more then previous quarter.

  • What is Revolution Medicines, Inc. Warrant's official website?

    The official website for Revolution Medicines, Inc. Warrant is revmed.com.

  • How can i contact Revolution Medicines, Inc. Warrant?

    Revolution Medicines, Inc. Warrant can be reached via phone at +65 04816801.

Revolution Medicines, Inc. Warrant company profile:

Revolution Medicines, Inc. Warrant

revmed.com
Exchange:

NASDAQ

Full time employees:

490

Industry:

Biotechnology

Sector:

Healthcare

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Its RAS(ON) inhibitors include RMC-6236 (multi), RMC-6291 (G12C), and RMC-9805 (G12D), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C), as well as programs focused on G12R and other targets. The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; and RMC-5552, which is in phase 1 clinical trial. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

+65 04816801
700 Saginaw Drive
Redwood City, 94063

CIK: 0001628171
:
: